TINA FUMO: Open Payments
NPI 1447965835 · LINDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 9 payments from 8 companies in 2025. Trend: 2023 $79 · 2024 $94 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 2 | $39 |
| Bioventus LLC | 1 | $29 |
| Novo Nordisk Inc | 1 | $24 |
| Astellas Pharma US Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: GELSYN-3, Ozempic, The Cologuard Plus Collection Kit, Veozah, MOUNJARO, Korlym, Cologuard Collection Kit, GARDASIL 9.
Industry payments across NJ — which companies pay providers there.
